Clinical Trial Update: Comprehensive Segmental Revision System

View source ↗

Summary

Clinical trial update for Zimmer Biomet's Comprehensive Segmental Revision System; the study is active but not recruiting, with indications involving cancer (on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Rheumatoid Arthritis

Drugs mentioned

• Comprehensive Segmental Revision System

Snippet

Sponsor: Zimmer Biomet | Conditions: Degenerative Disease, Oncology | Status: ACTIVE_NOT_RECRUITING